Hospital de la Familia
Medication treatment for multiple sclerosis in Mexico typically costs from $2,000 to $4,000 depending on the therapy type. Prices vary based on whether patients receive oral medications, self-injectables, or clinical infusions. In the US, similar treatments cost around $18,500 on average. Patients in Mexico save approximately 84% compared to US retail pharmacy prices. Most medical plans in Mexico include specialist consultations and initial blood work.
Bookimed Expert Insight: Choosing clinics in Monterrey or Mexicali provides a strategic balance of cost and accessibility. Alivia Clinica Monterrey manages approximately 4,000 patients annually, suggesting high proficiency in chronic care protocols. For US-based patients, Hospital de la Familia offers a boutique experience located steps from the Calexico border. This reduces travel overhead while maintaining high standards accredited by the General Health Council of Mexico.
| Mexico | Turkey | Austria | |
| Medication treatment for multiple sclerosis | from $2,000 | from $2,500 | from $2,000 |
| Ocrevus (ocrelizumab) | from $22,000 | from $10,000 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Medication treatment for multiple sclerosis upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Medication treatment for multiple sclerosis and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Medication treatment for multiple sclerosis journey.
Medication treatment for multiple sclerosis in Mexico can offer significant cost savings, but it's crucial to weigh the potential benefits against the risks.
| Pros | Cons |
|---|---|
| Lower costs. Treatment costs in Mexico for medications like Ocrelizumab are typically 50% less than the $50,000–$100,000 annual cost in the US, with savings often exceeding $25,000 per year. | Safety concerns. Potential risks include infusion reactions (up to 34%) and infection rates of 2–4%. These are similar to rates reported in the US when medications are administered by qualified neurologists. |
| Qualified neurologists. Neurologists are certified by the Mexican Council of Neurology, with many trained in US or European fellowship programs and extensive experience with MS therapies. | Follow-up care. Ongoing monitoring and lab tests may require coordination between Mexican and home-country providers, which can be logistically challenging but is manageable with proper planning. |
| Modern facilities. Major clinics in cities like Tijuana and Cancun are accredited by COFEPRIS and often meet JCI or ISO standards. Medications are sourced from FDA-approved manufacturers such as Roche. | Different regulatory standards. COFEPRIS standards differ from the FDA, but top clinics use FDA-approved drugs and follow international treatment protocols. |
| Personalized dosing schedules. Initial dosing, followed by a second dose after 15 days and a third at 6 months, allows for tailored treatment based on neurologist assessment. | Travel logistics. Multiple visits may be needed for dosing and follow-up, but many clinics help coordinate appointments to minimize travel burden. |
| Personal coordinator support. Bookimed’s medical coordinator helps compare clinics, request personalized quotes, and manage treatment logistics at no additional cost. |
It's crucial to thoroughly research clinics and verify neurologist credentials before making a decision. When performed by qualified specialists in reputable facilities, medication treatment for multiple sclerosis in Mexico can offer both safety and value.
The best medication treatment for multiple sclerosis clinics in Mexico hold JCI and General Health Council accreditations, operating in cities like Puerto Vallarta and Mexicali. According to Bookimed’s ranking, the top clinics are Hospital de la Familia, Alivia Clinica Monterrey, and Alivia Clinica Mexico City. They stand out for decades of experience in neurology and regenerative medicine, board-certified specialists, and internationally recognized protocol development. When choosing a provider, look for General Health Council accreditation, board-certified neurologists, and proven treatment outcomes, with cost-effective options. Always consult a qualified neurologist before making a decision.
Day 1
Day 2
Day 3
Day 4 to Day 14
Week 3
Week 4
Week 5
Note: Each patient"s journey with multiple sclerosis differs. This plan is a general guideline and may be adjusted based on individual needs.
Head of Teaching at Puerto Vallarta Regional Hospital – Dr. Perez combines clinical expertise with medical education leadership.
Most major disease-modifying therapies for multiple sclerosis are approved in Mexico by the Federal Commission for the Protection against Sanitary Risks. This includes high-efficacy infusions like ocrelizumab and natalizumab, alongside oral medications and traditional injectables, often available within two years of US approval.
Bookimed Expert Insight: Patient volume data shows Mexico serves 750 requests annually, ranking it 6th globally for medical travel. Specialized centers like Alivia Clinica Monterrey handle 4,000 patients every year. This high volume often ensures more consistent supply chains for biological therapies compared to smaller regional centers.
Patient Consensus: Patients emphasize that private neurology care is the best gateway for securing newer therapies. They recommend searching by active ingredient names rather than US brands when visiting Mexican pharmacies.
Medical care in Mexican multiple sclerosis clinics is safe when conducted in internationally accredited hospitals or specialized infusion centers. Safety relies on choosing facilities holding CSG Accreditation or COFEPRIS certification. Top-tier private clinics in Mexico City, Monterrey, and Mexicali provide care levels comparable to US standards.
Bookimed Expert Insight: Quality indicators for MS care often hide in the patient volume and hospital infrastructure. Alivia Clinica Monterrey serves 4,000 patients annually, demonstrating the high throughput required for clinical proficiency. Selecting a boutique hospital like Hospital de la Familia in Mexicali provides the added safety of 32 private rooms and immediate proximity to the USA border for care continuity.
Patient Consensus: Real experiences highlight that safety improves when patients verify the clinic is a formal neurology practice. Many advise demanding baseline bloodwork and scheduled MRI follow-ups to maintain a unified treatment regimen across borders.
Mexico offers a full spectrum of Disease-Modifying Therapies (DMTs) for multiple sclerosis, including oral, injectable, and infusion medications. Patients can access high-efficacy treatments like Ocrevus and Tysabri, alongside biosimilar options like Rituximab, through private clinics in Mexico City, Monterrey, and Mexicali.
Bookimed Expert Insight: While Ocrevus ranges from $22,000 to $35,000, many patients find Rituximab biosimilars far more accessible. Specialty infusion centers like Alivia Clinica in Monterrey and Mexico City manage high patient volumes. They often provide more reliable refrigerated storage and supply chains than general pharmacies.
Patient Consensus: Patients emphasize that securing a reliable monthly supply is more critical than finding the newest drug. Many highlight that private channels offer significantly better consistency for high-efficacy infusions compared to public health systems.
Mexico offers several high-efficacy treatments for aggressive and progressive multiple sclerosis, including hematopoietic stem cell transplantation (HSCT) and advanced monoclonal antibodies like ocrelizumab. These therapies target active inflammatory cycles to slow disability progression in patients who often face strict eligibility barriers or long waitlists elsewhere.
Bookimed Expert Insight: Patients seeking high-efficacy therapies like ocrelizumab can save up to 84% in Mexico compared to US costs. While outpatient clinics exist, Choosing a CSG-accredited hospital like Hospital de la Familia ensures access to full neuro-rehabilitation and emergency support during intensive infusion cycles.
Patient Consensus: Many feel that progressive MS is still treatable if active inflammation is present. Patients recommend bringing detailed MRI reports and relapse timelines to secure aggressive therapy plans quickly.
Follow-up care for multiple sclerosis treatment in Mexico uses a collaborative model. You complete initial monitoring at clinics like Hospital de la Familia or Alivia Clinica Monterrey before transitioning to a local neurologist. This hybrid approach ensures continuity through medical record exchanges and pre-arranged remote telemedicine consultations.
Bookimed Expert Insight: High-volume centers like Alivia Clinica, which serves 4,000 patients annually, often provide digital copies of lab results immediately. I recommend patients choose clinics near the border, such as those in Mexicali, to simplify future physical follow-up visits if travel becomes necessary for repeat infusions.
Patient Consensus: Success depends on building a two-doctor plan. Most patients emphasize securing a local specialist willing to review foreign medical records before traveling to ensure seamless prescription continuity and urgent care at home.
Advanced Multiple Sclerosis (MS) therapies in Mexico include Autologous Hematopoietic Stem Cell Transplantation (AHSCT), high-efficacy biological infusions like Ocrevus, and regenerative Mesenchymal Stem Cell (MSC) protocols. These interventions target neuroinflammation and immune system resetting, often providing faster access to specialized care than US or European systems.
Bookimed Expert Insight: Patients often focus on stem cells, but Mexico’s real advantage is rapid access to high-efficacy infusions. While US wait times can be months, private clinics like Alivia Clinica in Monterrey serve 4,000 patients annually with minimal delays. Choosing a facility with CSG Accreditation ensures the clinic meets government-verified safety standards for these intensive protocols.
Patient Consensus: Many patients emphasize that true medical advancement in Mexico means structured care with MRI monitoring and JCV risk screening. They warn against outpatient `cell shots,` preferring centers that coordinate results with home neurologists for long-term safety.